Partner, Baird Capital
Mike Liang joined Baird Capital in 2006 and concentrates on healthcare investments. Prior to joining Baird Capital, Mike Liang was a venture investor with Advent Venture Partners and before that, served in an operating role as a Director of R&D at Cortek, a spinal orthopedics company. Mike Liang is currently a member of the board of directors of Amphora Medical, GenomeDx Biosciences, Insightra Medical, Palyon Medical, PathCentral, Veniti, and Zurex Pharma. He was previously a board member of Interlace Medical before its acquisition in 2011 and a board observer of TomoTherapy before its public offering.